Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

赵侠,段京莉,刘晓,周颖,梁雁,孙葳,崔一民
DOI: https://doi.org/10.3969/j.issn.1001-6821.2009.04.006
2009-01-01
Abstract:Objective To study the pharmacokinetics and bioequivalence of risperidone film-coated tablets in healthy volunteers.Methods A single administration of 2 mg risperidone of test and reference formulation was given to 23 healthy male volunteers according to an open,randomized,cross-over design.The concentration of risperidone and 9-hydrorisperidone were determined by HPLC-MS/MS.The main pharmacokinetics were calculated and bioequivalence of two formulations were evaluated.Results The main pharmacokinetic parameters of test and reference formulation were as follows,risperidone:AUC0~t were(94.76±82.93)and(103.05±117.71)ng·h·mL-1,AUC0~1 were(96.72±84.52)and(105.19±119.36)ng·h·mL-1,Cmax were(15.91±5.63)and(16.21±11.56)ng·mL-1,tmaxwere(1.14±0.73)and(1.15±0.54)h,t1/2 were(7.32±5.94)and(7.44±6.50)h,respectively.The relative bioavailability of risperidone was(106.68±40.21)%;9-hydrorisperidone:AUC0~96h were(268.56±85.20)and(279.64±117.86)ng·h·mL-1,AUC0~∞were(282.74±87.46)and(294.28±120.32)ng·h·mL-1,Cmax were(10.84±4.69)and(11.11±4.80)ng·mL-1,tmax were(3.35±2.32)and(4.48±2.76)h,t1/2 were(23.18±3.26)and(23.12±4.31)h,respectively.The relative bioavailability of 9-hydrorisperidone was(101.37±27.23)%.Conclusion The two formulations were bioequivalent.
What problem does this paper attempt to address?